The purpose of this Request for Applications (RFA) is to attract PhD and Masters candidates within the following research fields, which will be given preference: Biostatistics, Bioethics, Bioinformatics, Data Science, Digital Health, Demography, Epidemiology, Environmental Public Health, Evolutionary Virology, Implementation and Translational Science, Health Economics, Genomics, Immunology and Structural Biology.

Funding opportunity for emerging researchers who are at the late stages of their PhDs (last 12-months). The funds can be used for dedicated time to spend on their research activities, pay for work relief, or any justifiable intervention.

The SAMRC, in collaboration with the DSTI, invites applications for the submission of existing longitudinal patient cohort samples to be considered for inclusion in the pilot phase of the South African 110,000 Human Genome Programme (SA110K-HGP).

Together with the Australian National Health and Medical Research Council (NHMRC), the South African Medical Research Council (SAMRC) is inviting investigators to submit applications with a focus on implementation research, addressing strategies for strengthening of health systems to improve equity in high quality care and health outcomes and reduce the prevalence and impact of non-communicable diseases.

This RFA is an open call for researchers engaged in health research from all recognised South African research institutions for the establishment of new SAMRC Extramural Research Units (EMUs). These new EMUs should provide scientific leadership in key research areas and conduct research where important research questions cannot easily be addressed through short-term grants.

The Human Frontier Science Program Organization, in collaboration with its South African members, the South African Medical Research Council and the National Research Foundation, invites applications for the following HFSP funding opportunities for 2026: HFSP Research Grants; HFSP Postdoctoral Fellowships; HFSP Awardees Meeting

The European Partnership for Personalised Medicine, EP PerMed, supported by the European Union under Horizon Europe, Grant Agreement N° 101137129, has launched its second joint transnational call (JTC2025) for proposals on “Pharmacogenomic strategies for personalised medicine approaches (PGxPM2025)”. In total, 35 funding organisations participate in this call with an available budget of over 36.5 Mio. € (approx.).